On August 28, 2019 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported that Neurocrine Biosciences management will present at the following investor conferences (Press release, Neurocrine Biosciences, AUG 28, 2019, View Source [SID1234539085]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Matt Abernethy, Chief Financial Officer, will present at the Baird 2019 Global Healthcare Conference at 8:30 a.m. ET on Wednesday, Sept. 4, 2019, in New York.
Kevin Gorman, Chief Executive Officer, will present at the Morgan Stanley 17th Annual Healthcare Conference at 11:10 a.m. ET on Tuesday, Sept. 10, 2019, in New York.
The live presentations will be webcast and may be accessed on the Company’s website under Investors at www.neurocrine.com. A replay of the presentations will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

On August 28, 2019 Cerus Corporation (Nasdaq: CERS) reported that the Company will participate in two upcoming investor conferences (Press release, Cerus, AUG 28, 2019, View Source [SID1234539054]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019, at 12:15 p.m. EDT. The conference will be held at the InterContinental New York Barclay in New York City.
William ‘Obi’ Greenman and Kevin D. Green, Cerus’ vice president finance and chief financial officer, are scheduled to present at 17th Annual Morgan Stanley Healthcare Conference on Monday, September 9, 2019, at 1:05 p.m. EDT. The conference will be held at the Grand Hyatt New York in New York City.
Live webcasts of the presentations will be available on the Investor Relations page of the Cerus web site at View Source Replays of the presentations will be available for approximately two weeks following the completion of the events.

On August 28, 2019 TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration through our license to Santen Pharmaceutical Co. Ltd., and utilizing our product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., reported that Charles Theuer, M.D., Ph.D., President and CEO, will present at the 4th annual Disruptive Growth Conference in New York on Wednesday, September 4th, at 1:40 PM EDT (Press release, Tracon Pharmaceuticals, AUG 28, 2019, View Source [SID1234539070]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access a live webcast of the presentation, please visit the "Events and Presentations" page within the "Investors" section of the TRACON Pharmaceuticals website at www.traconpharma.com. A replay of the webcast will be available on the website for 60 days following the event.

On August 28, 2019 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is reported at the 2019 Wells Fargo Healthcare Conference at the Westin Copley Place in Boston, Mass., on Wednesday, Sept. 4, 2019 (Press release, Edwards Lifesciences, AUG 28, 2019, View Source [SID1234539086]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Michael A. Mussallem, chairman and chief executive officer, and Scott B. Ullem, chief financial officer, are scheduled to speak to conference attendees at 9:05 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at View Source An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

On August 28, 2019 Clovis Oncology, Inc. (Nasdaq: CLVS) reported that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the 2019 Wells Fargo Healthcare Conference on Thursday, September 5, 2019 at 8:35 AM Eastern Time (Press release, Clovis Oncology, AUG 28, 2019, View Source [SID1234539055]). The conference will be held at the Westin Copley Place in Boston, MA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.